Determination and analysis of whole genome sequence of recombinant GII.6[P7] norovirus in Ningxia, China.


Journal

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
ISSN: 1567-7257
Titre abrégé: Infect Genet Evol
Pays: Netherlands
ID NLM: 101084138

Informations de publication

Date de publication:
11 2023
Historique:
received: 12 07 2023
revised: 31 08 2023
accepted: 05 09 2023
medline: 6 11 2023
pubmed: 22 9 2023
entrez: 21 9 2023
Statut: ppublish

Résumé

While the GII.4 norovirus was the predominant genotype, non-GII.4 genotype was increasingly focused since the non-GII.4 genotype caused regional epidemics. In this study, the detection rate was16.51% (183/1108) in Ningxia from January to December 2020. Among identified genotypes, GII.4[P31] and GII.4[P16] were the dominant genotypes (n = 20 and 18, respectively) while GII.6[P7] was the main type (n = 6) in non-GII.4 strains which was mainly detected in from May to July. The whole genome sequences of the norovirus diarrhea samples identified as GII.6 [P7] with Ct ≤ 30 collected in 2020 were determined. In this study, the complete genome sequences of norovirus strains PL20-044 and QTX20-071 were identified and analyzed phylogenetically. Phylogenetic analysis of the ORF1and ORF2 regions showed that these strains evolved from the GII·P7-GII.6 strains detected in recent years from different country. The results showed that PL20-044 had intra-type recombination with GII·P7-GII.6c and GII·P7-GII.6a, while QTX20-071 had intre-type recombination within GII·P7-GII.6a. The evolutionary rates of the RdRp gene region of the GII·P7 genotype and the VP1 gene region of the GII.6 genotype were 2.91 × 10

Identifiants

pubmed: 37734510
pii: S1567-1348(23)00097-7
doi: 10.1016/j.meegid.2023.105499
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

105499

Informations de copyright

Copyright © 2023. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest We declare that we have no financial and personal relationships with other people or organization that can inappropriately influence our work, there is no professional or other personal interest of any nature or king in any product, service and/or company that could be construed as influencing the position presented in, or the review of, the manuscript entitled.

Auteurs

Qian Chen (Q)

Ningxia Center for Disease Prevention and Control, Yinchuan 750004, China; School of Public Health, Ningxia Medical University, Yinchuan 750001, China.

Jiangtao Ma (J)

Ningxia Center for Disease Prevention and Control, Yinchuan 750004, China. Electronic address: nxcdcmjt@sina.com.

Lei Gao (L)

Ningxia Center for Disease Prevention and Control, Yinchuan 750004, China; School of Public Health, Ningxia Medical University, Yinchuan 750001, China.

Ran Xian (R)

Ningxia Center for Disease Prevention and Control, Yinchuan 750004, China; School of Public Health, Ningxia Medical University, Yinchuan 750001, China.

Kaixin Wei (K)

Ningxia Center for Disease Prevention and Control, Yinchuan 750004, China; School of Public Health, Ningxia Medical University, Yinchuan 750001, China.

Anqi Shi (A)

Ningxia Center for Disease Prevention and Control, Yinchuan 750004, China; School of Public Health, Ningxia Medical University, Yinchuan 750001, China.

Fang Yuan (F)

Ningxia Center for Disease Prevention and Control, Yinchuan 750004, China.

Min Cao (M)

Ningxia Center for Disease Prevention and Control, Yinchuan 750004, China.

Yu Zhao (Y)

School of Public Health, Ningxia Medical University, Yinchuan 750001, China.

Miao Jin (M)

National Institute for Viral Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102211, China.

Wenhe Kuai (W)

Ningxia Center for Disease Prevention and Control, Yinchuan 750004, China.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH